1. Saeidi, H., Ismail, P., & Samudi Raju, C., et al. (2023). Genetic alterations in prostate cancer as diagnostic and prognostic markers. Malaysian Journal of Pathology, 45(2), 149–155.
2. Washington, C., Goldstein, D. A., & Moore, A., et al. (2022). Health Disparities in Prostate Cancer and Approaches to Advance Equitable Care. American Society of Clinical Oncology Educational Book, 42, 1–6.
3. Liu, J., Dong, L., & Zhu, Y., et al. (2022). Prostate cancer treatment - China’s perspective. Cancer Letters, 550, 215927.
4. Sung, H., Ferlay, J., & Siegel, R. L., et al. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer Journal for Clinicians, 71(3), 209–249.
5. Wang, G., Zhao, D., & Spring, D. J., et al. (2018). Genetics and biology of prostate cancer. Genes Dev, 32(17-18), 1105–1140.